These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11757652)

  • 1. Pivalase catalytic antibodies: towards abzymatic activation of prodrugs.
    Bensel N; Reymond MT; Reymond JL
    Chemistry; 2001 Nov; 7(21):4604-12. PubMed ID: 11757652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A competitive immunoassay for the detection of esterolytic activity of antibodies and enzymes.
    Benedetti F; Berti F; Flego M; Resmini M; Bastiani E
    Anal Biochem; 1998 Feb; 256(1):67-73. PubMed ID: 9466799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective chemotherapeutic strategies using catalytic antibodies: a common pro-moiety for antibody-directed abzyme prodrug therapy.
    Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2002 Nov; 269(1-2):269-81. PubMed ID: 12379367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O6-alkylguanine-DNA alkyltransferase inactivation by ester prodrugs of O6-benzylguanine derivatives and their rate of hydrolysis by cellular esterases.
    Dolan ME; Roy SK; Garbiras BJ; Helft P; Paras P; Chae MY; Moschel RC; Pegg AE
    Biochem Pharmacol; 1998 May; 55(10):1701-9. PubMed ID: 9634007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic activity of certain antibodies as a potential tool for drug synthesis and for directed prodrug therapies.
    Wójcik T; Kieć-Kononowicz K
    Curr Med Chem; 2008; 15(16):1606-15. PubMed ID: 18673227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient and selective p-nitrophenyl-ester-hydrolyzing antibodies elicited by a p-nitrobenzyl phosphonate hapten.
    Tawfik DS; Lindner AB; Chap R; Eshhar Z; Green BS
    Eur J Biochem; 1997 Mar; 244(2):619-26. PubMed ID: 9119032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection strategies for catalytic antibodies.
    Reymond JL
    J Immunol Methods; 2002 Nov; 269(1-2):125-31. PubMed ID: 12379357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A catalytic antibody isomerizing a delta 5-3-cétostéroïde.
    Khettal B; de Lauzon S; Desfosses B; Ushida S; Marquet A
    C R Acad Sci III; 1994 May; 317(5):381-5. PubMed ID: 7994617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-Directed Chemical Mutations on Abzymes: Large Rate Accelerations in the Catalysis by Exchanging the Functionalized Small Nonprotein Components.
    Ishikawa F; Shirahashi M; Hayakawa H; Yamaguchi A; Hirokawa T; Tsumuraya T; Fujii I
    ACS Chem Biol; 2016 Oct; 11(10):2803-2811. PubMed ID: 27552288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crossreactivity, efficiency and catalytic specificity of an esterase-like antibody.
    Gigant B; Charbonnier JB; Eshhar Z; Green BS; Knossow M
    J Mol Biol; 1998 Dec; 284(3):741-50. PubMed ID: 9826512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-catalyzed removal of the p-nitrobenzyl ester protecting group: the molecular basis of broad substrate specificity.
    Kurihara S; Tsumuraya T; Suzuki K; Kuroda M; Liu L; Takaoka Y; Fujii I
    Chemistry; 2000 May; 6(9):1656-62. PubMed ID: 10839182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected acetylcholinesterase activity of cocaine esterases.
    Rogers CJ; Eubanks LM; Dickerson TJ; Janda KD
    J Am Chem Soc; 2006 Dec; 128(48):15364-5. PubMed ID: 17131989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyclonal antibody catalytic variability.
    Stephens DB; Thomas RE; Stanton JF; Iverson BL
    Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):127-34. PubMed ID: 9576860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate-Competitive Activity-Based Profiling of Ester Prodrug Activating Enzymes.
    Xu H; Majmudar JD; Davda D; Ghanakota P; Kim KH; Carlson HA; Showalter HD; Martin BR; Amidon GL
    Mol Pharm; 2015 Sep; 12(9):3399-407. PubMed ID: 26262434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The scope of antibody catalysis.
    Jacobsen JR; Schultz PG
    Curr Opin Struct Biol; 1995 Dec; 5(6):818-24. PubMed ID: 8749371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for 'lock and key' character in an anti-phosphonate hydrolytic antibody catalytic site augmented by non-reaction centre recognition: variation in substrate selectivity between an anti-phosphonate antibody, an anti-phosphate antibody and two hydrolytic enzymes.
    Sonkaria S; Boucher G; Flórez-Olvarez J; Said B; Hussain S; Ostler EL; Gul S; Thomas EW; Resmini M; Gallacher G; Brocklehurst K
    Biochem J; 2004 Jul; 381(Pt 1):125-30. PubMed ID: 15053743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of covalent binding antibodies.
    Armentano F; Knight T; Makker S; Tramontano A
    Immunol Lett; 2006 Feb; 103(1):51-7. PubMed ID: 16297987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme/abzyme prodrug activation systems: potential use in clinical oncology.
    Nishi Y
    Curr Pharm Des; 2003; 9(26):2113-30. PubMed ID: 14529409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bait and switch hapten strategy generates catalytic antibodies for phosphodiester hydrolysis.
    Wentworth P; Liu Y; Wentworth AD; Fan P; Foley MJ; Janda KD
    Proc Natl Acad Sci U S A; 1998 May; 95(11):5971-5. PubMed ID: 9600901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An investigation of antibody acyl hydrolysis catalysis using a large set of related haptens.
    Odenbaugh AL; Helms ED; Iverson BL
    Bioorg Med Chem; 2000 Feb; 8(2):413-26. PubMed ID: 10722164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.